Providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory syndrome-related illnesses.

HB 1741 Providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off label use to treat coronavirus infections causing respiratory syndrome related illnesses

Pennsylvania 2021-2022 Regular Session

Providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory syndrome-related illnesses.
HB-1741


About HB-1741

An Act providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory syndrome-related illnesses.

  

Bill Texts

Amended

Amended

Introduced

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

Sponsors (18)

Votes

House Floor: HB 1741 PN 2713, 2021 A4343

06/14/2022

Yeas: 111 | Nays: 89
Support by Party

     

House Health: Report Bill As Amended

02/07/2022

Yeas: 15 | Nays: 10
Support by Party

   

House Health: Adopt Amendment A03628

02/07/2022

Yeas: 25 | Nays: 0
Support by Party

   

Sponsors by party

  

Bill Sponsors

History

Second Consideration, With Amendments

06/14/2022

Re-committed To Appropriations

06/14/2022

Removed From Table

06/08/2022

Removed From Table

06/07/2022

Laid On The Table

06/07/2022

Reported As Amended

02/07/2022

First Consideration

02/07/2022

Laid On The Table

02/07/2022

Referred To Health

07/30/2021